Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Does Granular Activated Carbon with Chlorination Produce Safer Drinking Water? From Disinfection Byproducts and Total Organic Halogen to Calculated Toxicity.

Cuthbertson AA, Kimura SY, Liberatore HK, Summers RS, Knappe DRU, Stanford BD, Maness JC, Mulhern RE, Selbes M, Richardson SD.

Environ Sci Technol. 2019 May 21;53(10):5987-5999. doi: 10.1021/acs.est.9b00023. Epub 2019 May 10.

PMID:
31038939
2.

Nucleophosmin Phosphorylation as a Diagnostic and Therapeutic Target for Ischemic AKI.

Wang Z, Salih E, Igwebuike C, Mulhern R, Bonegio RG, Havasi A, Borkan SC.

J Am Soc Nephrol. 2019 Jan;30(1):50-62. doi: 10.1681/ASN.2018040401.

PMID:
30573638
3.

Evaluating Activated Carbon Adsorption of Dissolved Organic Matter and Micropollutants Using Fluorescence Spectroscopy.

Shimabuku KK, Kennedy AM, Mulhern RE, Summers RS.

Environ Sci Technol. 2017 Mar 7;51(5):2676-2684. doi: 10.1021/acs.est.6b04911. Epub 2017 Feb 14.

PMID:
28117982
4.

Proteinuria causes dysfunctional autophagy in the proximal tubule.

Nolin AC, Mulhern RM, Panchenko MV, Pisarek-Horowitz A, Wang Z, Shirihai O, Borkan SC, Havasi A.

Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1271-F1279. doi: 10.1152/ajprenal.00125.2016. Epub 2016 Aug 31.

5.

Evidence of change in brain activity among childhood cancer survivors participating in a cognitive remediation program.

Zou P, Li Y, Conklin HM, Mulhern RK, Butler RW, Ogg RJ.

Arch Clin Neuropsychol. 2012 Dec;27(8):915-29. doi: 10.1093/arclin/acs095. Epub 2012 Oct 18.

6.

To be.

Mulhern RM.

Home Healthc Nurse. 2012 Jan;30(1):63-4. doi: 10.1097/NHH.0b013e31823aa89d.

PMID:
22173623
7.

Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial.

Conklin HM, Helton S, Ashford J, Mulhern RK, Reddick WE, Brown R, Bonner M, Jasper BW, Wu S, Xiong X, Khan RB.

J Pediatr Psychol. 2010 Mar;35(2):144-55. doi: 10.1093/jpepsy/jsp044. Epub 2009 May 22.

8.

A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy.

Butler RW, Copeland DR, Fairclough DL, Mulhern RK, Katz ER, Kazak AE, Noll RB, Patel SK, Sahler OJ.

J Consult Clin Psychol. 2008 Jun;76(3):367-78. doi: 10.1037/0022-006X.76.3.367.

9.

Brain structural abnormalities in survivors of pediatric posterior fossa brain tumors: a voxel-based morphometry study using free-form deformation.

Zhang Y, Zou P, Mulhern RK, Butler RW, Laningham FH, Ogg RJ.

Neuroimage. 2008 Aug 1;42(1):218-29. doi: 10.1016/j.neuroimage.2008.04.181. Epub 2008 Apr 23.

10.

Do cosmetics enhance female Caucasian facial attractiveness?

Mulhern R, Fieldman G, Hussey T, Lévêque JL, Pineau P.

Int J Cosmet Sci. 2003 Aug;25(4):199-205. doi: 10.1046/j.1467-2494.2003.00188.x.

PMID:
18494902
11.

Neural correlates of a clinical continuous performance test.

Ogg RJ, Zou P, Allen DN, Hutchins SB, Dutkiewicz RM, Mulhern RK.

Magn Reson Imaging. 2008 May;26(4):504-12. Epub 2008 Feb 20.

PMID:
18068933
12.

Brief report: sluggish cognitive tempo among pediatric survivors of acute lymphoblastic leukemia.

Reeves CB, Palmer S, Gross AM, Simonian SJ, Taylor L, Willingham E, Mulhern RK.

J Pediatr Psychol. 2007 Oct;32(9):1050-4. Epub 2007 Oct 12.

PMID:
17933846
13.

Ectasia of the basilar artery in children with sickle cell disease: relationship to hematocrit and psychometric measures.

Steen RG, Langston JW, Ogg RJ, Manci E, Mulhern RK, Wang W.

J Stroke Cerebrovasc Dis. 1998 Jan-Feb;7(1):32-43.

PMID:
17895054
14.

Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial.

Conklin HM, Khan RB, Reddick WE, Helton S, Brown R, Howard SC, Bonner M, Christensen R, Wu S, Xiong X, Mulhern RK.

J Pediatr Psychol. 2007 Oct;32(9):1127-39. Epub 2007 Jun 14.

PMID:
17569711
15.

Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy.

Kiehna EN, Mulhern RK, Li C, Xiong X, Merchant TE.

J Clin Oncol. 2006 Nov 20;24(33):5283-90.

PMID:
17114662
16.

Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function.

Merchant TE, Kiehna EN, Kun LE, Mulhern RK, Li C, Xiong X, Boop FA, Sanford RA.

J Neurosurg. 2006 Feb;104(2 Suppl):94-102.

PMID:
16506496
17.

Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma.

Merchant TE, Kiehna EN, Li C, Shukla H, Sengupta S, Xiong X, Gajjar A, Mulhern RK.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):210-21. Epub 2006 Feb 10.

PMID:
16472938
18.

Factor analysis and validity of the Conners Parent and Teacher Rating Scales in childhood cancer survivors.

Helton SC, Corwyn RF, Bonner MJ, Brown RT, Mulhern RK.

J Pediatr Psychol. 2006 Mar;31(2):200-8. Epub 2005 Mar 3.

PMID:
16467320
19.

Early patterns of verbal memory impairment in children treated for medulloblastoma.

Nagel BJ, Delis DC, Palmer SL, Reeves C, Gajjar A, Mulhern RK.

Neuropsychology. 2006 Jan;20(1):105-12.

PMID:
16460226
20.

Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia.

Reddick WE, Shan ZY, Glass JO, Helton S, Xiong X, Wu S, Bonner MJ, Howard SC, Christensen R, Khan RB, Pui CH, Mulhern RK.

Cancer. 2006 Feb 15;106(4):941-9.

21.

Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies.

Fouladi M, Gilger E, Kocak M, Wallace D, Buchanan G, Reeves C, Robbins N, Merchant T, Kun LE, Khan R, Gajjar A, Mulhern R.

J Clin Oncol. 2005 Oct 1;23(28):7152-60.

PMID:
16192599
22.

Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma.

Merchant TE, Kiehna EN, Li C, Xiong X, Mulhern RK.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1546-54. Epub 2005 Aug 22.

PMID:
16115736
23.

Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.

Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A.

J Clin Oncol. 2005 Aug 20;23(24):5511-9.

PMID:
16110011
24.
25.

Using problem-solving skills training to reduce negative affectivity in mothers of children with newly diagnosed cancer: report of a multisite randomized trial.

Sahler OJ, Fairclough DL, Phipps S, Mulhern RK, Dolgin MJ, Noll RB, Katz ER, Varni JW, Copeland DR, Butler RW.

J Consult Clin Psychol. 2005 Apr;73(2):272-83.

PMID:
15796635
26.

Cognitive deficits in children with sickle cell disease.

Steen RG, Fineberg-Buchner C, Hankins G, Weiss L, Prifitera A, Mulhern RK.

J Child Neurol. 2005 Feb;20(2):102-7.

PMID:
15794173
27.

Attention and memory functioning among pediatric patients with medulloblastoma.

Reeves CB, Palmer SL, Reddick WE, Merchant TE, Buchanan GM, Gajjar A, Mulhern RK.

J Pediatr Psychol. 2006 Apr;31(3):272-80. Epub 2005 Mar 23.

PMID:
15788715
28.

Atypical white matter volume development in children following craniospinal irradiation.

Reddick WE, Glass JO, Palmer SL, Wu S, Gajjar A, Langston JW, Kun LE, Xiong X, Mulhern RK.

Neuro Oncol. 2005 Jan;7(1):12-9.

29.

Neurocognitive interventions for children and adolescents surviving cancer.

Butler RW, Mulhern RK.

J Pediatr Psychol. 2005 Jan-Feb;30(1):65-78. Review.

PMID:
15610986
30.

BOLD responses to visual stimulation in survivors of childhood cancer.

Zou P, Mulhern RK, Butler RW, Li CS, Langston JW, Ogg RJ.

Neuroimage. 2005 Jan 1;24(1):61-9.

PMID:
15588597
31.

Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.

Mulhern RK, Khan RB, Kaplan S, Helton S, Christensen R, Bonner M, Brown R, Xiong X, Wu S, Gururangan S, Reddick WE.

J Clin Oncol. 2004 Dec 1;22(23):4795-803. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

PMID:
15570081
32.

White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.

Fouladi M, Chintagumpala M, Laningham FH, Ashley D, Kellie SJ, Langston JW, McCluggage CW, Woo S, Kocak M, Krull K, Kun LE, Mulhern RK, Gajjar A.

J Clin Oncol. 2004 Nov 15;22(22):4551-60.

PMID:
15542806
33.

Abnormal hippocampal development in children with medulloblastoma treated with risk-adapted irradiation.

Nagel BJ, Palmer SL, Reddick WE, Glass JO, Helton KJ, Wu S, Xiong X, Kun LE, Gajjar A, Mulhern RK.

AJNR Am J Neuroradiol. 2004 Oct;25(9):1575-82.

34.

Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma.

Merchant TE, Mulhern RK, Krasin MJ, Kun LE, Williams T, Li C, Xiong X, Khan RB, Lustig RH, Boop FA, Sanford RA.

J Clin Oncol. 2004 Aug 1;22(15):3156-62.

PMID:
15284268
35.

Late neurocognitive sequelae in survivors of brain tumours in childhood.

Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE.

Lancet Oncol. 2004 Jul;5(7):399-408. Review.

PMID:
15231246
36.

Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood.

Mulhern RK, White HA, Glass JO, Kun LE, Leigh L, Thompson SJ, Reddick WE.

J Int Neuropsychol Soc. 2004 Mar;10(2):180-9.

PMID:
15012838
37.

Neurocognitive sequelae of childhood cancers and their treatment.

Mulhern RK, Butler RW.

Pediatr Rehabil. 2004 Jan-Mar;7(1):1-14; discussion 15-6. Review. No abstract available.

PMID:
14744668
38.

Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma.

Palmer SL, Gajjar A, Reddick WE, Glass JO, Kun LE, Wu S, Xiong X, Mulhern RK.

Neuropsychology. 2003 Oct;17(4):548-55.

PMID:
14599268
39.

Atonic seizures in survivors of childhood cancer.

Khan RB, Marshman KC, Mulhern RK.

J Child Neurol. 2003 Jun;18(6):397-400.

PMID:
12886974
40.

Neurocognitive late effects in pediatric cancer.

Mulhern RK, Palmer SL.

Curr Probl Cancer. 2003 Jul-Aug;27(4):177-97. Review. No abstract available.

PMID:
12855950
41.

Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors.

Reddick WE, White HA, Glass JO, Wheeler GC, Thompson SJ, Gajjar A, Leigh L, Mulhern RK.

Cancer. 2003 May 15;97(10):2512-9.

42.

Cognitive impairment in children with hemoglobin SS sickle cell disease: relationship to MR imaging findings and hematocrit.

Steen RG, Miles MA, Helton KJ, Strawn S, Wang W, Xiong X, Mulhern RK.

AJNR Am J Neuroradiol. 2003 Mar;24(3):382-9.

43.

Survival and functional outcome of children with hypothalamic/chiasmatic tumors.

Fouladi M, Wallace D, Langston JW, Mulhern R, Rose SR, Gajjar A, Sanford RA, Merchant TE, Jenkins JJ, Kun LE, Heideman RL.

Cancer. 2003 Feb 15;97(4):1084-92.

44.

Decline in corpus callosum volume among pediatric patients with medulloblastoma: longitudinal MR imaging study.

Palmer SL, Reddick WE, Glass JO, Gajjar A, Goloubeva O, Mulhern RK.

AJNR Am J Neuroradiol. 2002 Aug;23(7):1088-94.

45.
46.

Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001.

Merchant TE, Kiehna EN, Sanford RA, Mulhern RK, Thompson SJ, Wilson MW, Lustig RH, Kun LE.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):533-42.

PMID:
12062594
47.

Problem-solving skills training for mothers of children with newly diagnosed cancer: a randomized trial.

Sahler OJ, Varni JW, Fairclough DL, Butler RW, Noll RB, Dolgin MJ, Phipps S, Copeland DR, Katz ER, Mulhern RK.

J Dev Behav Pediatr. 2002 Apr;23(2):77-86.

PMID:
11943969
48.

Who can decide what is in a child's best interest? A problem-solving approach.

Makin G, Eden T, Mulhern RK.

Med Pediatr Oncol. 2001 Jun;36(6):649-51. No abstract available. Erratum in: Med Pediatr Oncol 2001 Jul;37(1):82.

PMID:
11344498
49.

Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

Palmer SL, Goloubeva O, Reddick WE, Glass JO, Gajjar A, Kun L, Merchant TE, Mulhern RK.

J Clin Oncol. 2001 Apr 15;19(8):2302-8.

PMID:
11304784
50.

Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer.

Thompson SJ, Leigh L, Christensen R, Xiong X, Kun LE, Heideman RL, Reddick WE, Gajjar A, Merchant T, Pui CH, Hudson MM, Mulhern RK.

J Clin Oncol. 2001 Mar 15;19(6):1802-8.

PMID:
11251012

Supplemental Content

Loading ...
Support Center